- ≥ 1 fill for atorvastatin or simvastatin (not including combination therapy) between
01 July 2006 and 30 November 2008
- Age ≥ 65 years as of the year of index date
- Continuous enrollment with medical and pharmacy benefits during the analytic period
- 1 or more fills for a statin or other dyslipidemia medication in the 12-month
pre-index period
- A pharmacy fill for clopidogrel or nitrates (except concomitant hydralazine) in the
12-month pre-index period
- Patients with evidence of a cardiovascular event in the 12-month pre-index period.
- Patients who received both atorvastatin and simvastatin on the index date
- Patients with unknown gender or region
- Patients who received dyslipidemia medications other than the index drug within 1
months (30 days) following the index date